Literature DB >> 8025346

The control of production and release of haemostatic factors in the endothelial cell.

J D Pearson1.   

Abstract

Endothelial cell products contribute to many aspects of the regulation of haemostasis. They include potent inhibitors of platelet aggregation (prostacyclin and nitric oxide) rapidly released in response to agonists such as thrombin. Similar agonists also induce the formation of platelet-activating factor by endothelium. Endothelial cell surface ectonucleotidase enzymes control the catabolism of platelet-active adenine nucleotides. The main source of the circulating coagulant cofactor von Willebrand factor is the endothelium, where it is stored in granules for agonist-triggered exocytosis and also secreted constitutively. Surface anticoagulant activities are due to the presence of antithrombin and thrombomodulin. Endothelial cells also secrete plasminogen activator and its inhibitor. Many of these reactions are significantly modulated by exposure of endothelium to cytokines or bacterial endotoxin, the most striking example being the new synthesis and surface expression of the procoagulant tissue factor (thromboplastin).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8025346     DOI: 10.1016/s0950-3536(05)80192-1

Source DB:  PubMed          Journal:  Baillieres Clin Haematol        ISSN: 0950-3536


  4 in total

1.  Investigating the two regimes of fibrin clot lysis: an experimental and computational approach.

Authors:  Franck Raynaud; Alexandre Rousseau; Daniel Monteyne; David Perez-Morga; Karim Zouaoui Boudjeltia; Bastien Chopard
Journal:  Biophys J       Date:  2021-08-10       Impact factor: 3.699

2.  Normal and perturbed endothelial cells from canine femoral arteries and femoral veins exhibit heterogeneity in hemostatic properties and growth characteristics.

Authors:  Ni-Hu Tang; Hong-I Chen; Li-Chun Lu; Kenneth M Meyers
Journal:  J Thromb Thrombolysis       Date:  2002-08       Impact factor: 2.300

3.  Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas.

Authors:  M Hoshino; Y Haraguchi; H Hirasawa; M Sakai; H Saegusa; K Hayashi; N Horita; H Ohsawa
Journal:  Crit Care       Date:  2001-02-26       Impact factor: 9.097

4.  P2 receptors in cardiovascular regulation and disease.

Authors:  David Erlinge; Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2007-09-21       Impact factor: 3.765

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.